London & Capital Asset Management »

AstraZeneca shares owned by London & Capital Asset Management

Quarter-by-quarter ownership of AstraZeneca shares owned by London & Capital Asset Management from 13F filings

Historical chart of London & Capital Asset Management investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by London & Capital Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by London & Capital Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $289k 3.1k 91.94

More positions owned by London & Capital Asset Management

Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Visa Com Cl A (V)
Thermo Fisher Scientific (TMO)
Ge Aerospace Com New (GE)
Cme (CME)
Ferguson Enterprises Common Stock New (FERG)
Interactive Brokers Group In Com Cl A (IBKR)
Marsh & McLennan Companies
Capital One Financial (COF)
International Business Machines (IBM)
Intercontinental Exchange (ICE)
Synopsys (SNPS)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)

View all positions for London & Capital Asset Management

Top funds holding AstraZeneca

PRIMECAP Management Company
Wellington Management Company
FMR
Fisher Investments
Franklin Resources
Capital Research and Management Company - Division 3
Goldman Sachs Group
Sanders Capital
Ameriprise Financial
Atlantic Trust
Dimensional Fund Advisors
BlackRock
Arrowstreet Capital, Limited Partnership
Citadel Advisors
Neuberger Berman Group

View all funds holding AstraZeneca